SFJ Pharmaceuticals, Inc.
Quick facts
Phase 3 pipeline
- Bentracimab (PB2452) Infusion · Hematology; Cardiovascular
Bentracimab is a monoclonal antibody that binds to and neutralizes unfractionated heparin (UFH), rapidly reversing its anticoagulant effects.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: